Personalis, Inc.

PSNL Healthcare Diagnostics & Research

Personalis, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $69.6 million, down 17.7% from fiscal 2024. In the quarter to June 2026, revenue grew 30.0%, EPS fell 30.4% and free cash flow fell 123.5%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

15.65 0.28 −1.76%
Market cap
$1.7B
P/E
0.0×
Fwd P/E
−10.5×
Dividend yield
—
F-score
4/9
Altman Z
3.35
Beneish M
−1.30
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17
Cash and Short Term Investments
239.95 185.01 114.18 167.66 287.06 203.29 128.29 19.74 22.62
Receivables
16.20 8.14 17.73 16.64 18.47 6.35 3.30 4.46 1.94
Inventory
6.14 5.94 10.47 8.59 5.61 5.64 4.61 3.43 0.82
Total current assets
267.95 203.02 146.74 199.70 318.23 220.72 139.58 29.56 26.18
Property, Plant, Equpment (Net)
44.82 48.27 57.37 61.94 19.65 11.83 14.11 11.45 6.34
Goodwill and Intangible Assets (Total)
— — — — — — — — 0.00
Long-term assets (Other)
6.28 2.53 3.14 4.59 4.83 2.02 1.76 0.66 1.04
Total non-current assets
66.21 67.25 78.36 93.00 78.30 24.12 17.71 12.11 —
Total Assets
334.16 270.27 225.10 292.70 396.53 244.84 157.29 41.67 —
Notes Payable
— — — — — — — 5.00 —
Accounts Payable
12.99 6.40 14.92 12.85 9.22 8.30 7.34 6.57 4.04
Accrued Expenses
25.08 21.63 23.94 19.01 18.11 11.30 6.65 3.39 —
Current Part of Capital Lease
— — — — — — — — 0.00
Current Part of Taxes to Pay
— — — — — — — — 0.00
Other current liabilities
1.56 3.10 8.37 1.26 3.98 21.03 35.98 42.90 27.34
Total current liabilities
39.63 31.13 47.23 33.13 31.31 40.64 49.96 57.85 48.99
Non-current Revenue (Deferred)
— — — — — — — — 0.00
Liabilities (Preferred Stock)
— — — — — — — 90.09 —
Minority Interests
— — — — — — — — 0.00
Non-current Liabilities (Other)
1.48 1.30 10.10 0.39 2.12 0.72 0.00 0.12 0.89
Total non-current liabilities
33.35 36.19 48.42 41.43 54.91 9.26 0.64 90.21 —
Total liabilities
72.98 67.31 95.66 74.56 86.23 49.90 50.60 148.06 —
Additional Paid In Capital
892.33 752.96 598.36 579.46 557.56 376.79 247.28 9.13 0.00
Preferred Stock (Total)
— — — — — — — — 0.00
Common Stock (Net)
0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Retained Earnings
(631.26) (549.99) (468.71) (360.41) (247.09) (181.87) (140.59) (115.50) (95.62)
Treasury Stock
— — — — — — — — 0.00
Shareholders Equity (Other)
— — — — — — — — 0.00
Common Equity (Total)
261.19 202.96 129.44 218.14 310.30 194.95 106.69 (106.39) (92.60)
Shareholders Equity (Total)
261.19 202.96 129.44 218.14 310.30 194.95 106.69 (106.39) —
Shareholders Equity and Liabilities (Total)
334.16 270.27 225.10 292.70 396.53 244.84 157.29 41.67 —
Shares (Common)
102.48 85.17 50.48 46.71 44.91 39.11 31.24 3.09 —
Shareholders Equity (Tangible)
261.19 202.96 129.44 218.14 310.30 194.95 106.69 (106.39) —
Net Debt
(239.95) (185.01) (114.18) (167.66) (287.06) (203.29) (128.29) (19.74) (22.62)
Total Debt
— — — 49.03 60.02 10.99 2.00 5.68 17.80

Fold the line items

In millions of $ except per-share values · columns are period end dates